treatment recommendations for high-risk biochemical recurrent prostate cancer
Published 7 months ago • 883 plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
1:51
management of biochemical recurrence in prostate cancer
-
2:53
use of salvage radiation therapy for biochemical recurrence of prostate cancer after prostatectomy
-
3:47
salvage radiotherapy in biochemically recurrent prostate cancer
-
3:07
salv-enza: srt enzalutamide in high-risk psa-recurrent prostate cancer after radical prostatectomy
-
23:28
identification of high risk disease and initial management of biochemical recurrence
-
2:26
managing biochemical relapse after radical prostatectomy
-
1:14
optimizing outcomes in psa recurrent prostate cancer
-
27:04
identification of high risk disease and initial management of biochemical recurrence
-
2:04
the treatment paradigm for prostate cancer patients with biochemical recurrence: paul nguyen, md
-
21:09
evaluation and management of psa recurrence after definitive treatment of localized prostate cancer
-
10:00
biochemical recurrence after local therapy: assessment and management
-
6:57
phase ii trial of enoblituzumab for patients with intermediate/high-risk localised prostate cancer
-
23:30
identification of high-risk disease and initial management of biochemical recurrence
-
1:11
what is the risk of recurrence for prostate cancer? | norton cancer institute
-
6:50
presto: intensified androgen blockade for biochemically recurrent prostate cancer
-
11:22
neoadjuvant androgen deprivation therapy in men with high-risk localized prostate cancer
-
1:01
dr. einstein on biochemical recurrence in prostate cancer
-
2:47
annihilating recurrent prostate cancer and decreasing side effects
-
17:18
identification of high-risk disease and initial management of biochemical recurrence